Combined ARHGEF6 and Tumor Mutational Burden may serve as a potential biomarker for immunotherapy of lung adenocarcinoma

ARHGEF6, a member of the Dbl-related guanylate exchanger (GEF) family, is highly expressed in gastric cancer and glioma. However, scientists still do not know whether it plays a pivotal role in the pathogenesis of lung adenocarcinoma（LUAD）. The prognostic significance of ARHGEF6 expression was asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Li, Wang, Sichu, Yang, Juanjuan, Zhang, Qing, Gu, Xue, Mo, Taoming, Luo, Yang, Zhang, Chenqian, Zhang, Jianguo, Liu, Yifei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432614/
https://www.ncbi.nlm.nih.gov/pubmed/37600416
http://dx.doi.org/10.1016/j.heliyon.2023.e18501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432614/
https://www.ncbi.nlm.nih.gov/pubmed/37600416
http://dx.doi.org/10.1016/j.heliyon.2023.e18501

Ejemplares similares